Profile
Dr. Dinah W.
Sah is a Scientific Advisor at VV Manager LLC.
She is on the Board of Directors at Circio Holding ASA. Dr. Sah was previously employed as a President and Director by TrustArc, Inc., a Chief Scientific Officer by Voyager Therapeutics, Inc., a Vice President-Research, CNS & Oncology by Alnylam Pharmaceuticals, Inc., an Associate Director-Research by Biogen Idec, Inc., and an Associate Director-Neurobiology by Signal Pharmaceuticals, Inc. She received her undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard University.
Dinah Sah active positions
| Companies | Position | Start |
|---|---|---|
| CIRCIO HOLDING ASA | Director/Board Member | 25/08/2026 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | - |
Former positions of Dinah Sah
| Companies | Position | End |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/06/2019 |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/2005 |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Corporate Officer/Principal | 01/01/1999 |
TrustArc, Inc.
TrustArc, Inc. Packaged SoftwareTechnology Services Develops an AI-powered data privacy and compliance management platform | President | - |
Training of Dinah Sah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
TrustArc, Inc.
TrustArc, Inc. Packaged SoftwareTechnology Services Develops an AI-powered data privacy and compliance management platform | Technology Services |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
- Stock Market
- Insiders
- Dinah Sah
















